In Reversal, Cambridge's Biogen to File for FDA Approval of Alzheimer's Drug

NBC 10 Boston

Oct 22, 2019

Shares of Biogen Inc. were up more than 40% Tuesday morning after the Cambridge drugmaker said it will file for approval of an Alzheimer's drug seven months after discontinuing dev…